rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524804 AUROPHARMA Group (A)

Aurobindo Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
1222.70   46.20   3.93%
Volume 125,981
Prev close 1,176.50
Day's H/L (Rs.) 1,228.10 - 1,179.10
52wk H/L (Rs.) 1,228.10 - 422.75
Mkt Cap (Rs. Cr) 35,678.39
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

AUROPHARMA

Aurobindo Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
1221.55   43.40   3.68%
Volume 1,405,898
Prev close 1178.15
Day's H/L (Rs.) 1,228.00 - 1,175.10
52wk H/L (Rs.) 1,228.00 - 423.10
Turnover (Rs. Lacs) 17,040.19
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Aurobindo Pharma Ltd.  (See all 2,329 market voices)   

140 Characters
  Cancel
Rkg - 14 hour(s) ago resi at 1172 / 1180 closing abv can go for 1317
#Aurobindo-Pharma-Ltd
Reply   |   Share
harish lobo - 1 week ago  Sir, closed above 1180 today. Do you think it will touch 1300 by next week itself?
Reply   |  Share
rkg - 1 week ago  @HL : hold expecting gud upside to 1265 / 1317. sup at 1145 / 1128
Reply   |  Share
rkg - 14 hours ago  lets waitttttt
Reply   |  Share
Ashwin-Amita PATEL - 20 hour(s) ago boom
#Aurobindo-Pharma-Ltd
Reply   |   Share

Realtime news for Aurobindo Pharma Ltd. (See all 833 news)

30 January 2015, 08:06
Active Pharmaceutical Ingredients (API) Market in India 2015-2019: Key Vendors are Aurobindo Pharma, Cipla and Dr. Reddy's Laboratories - 14 hour(s) ago
Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis - 1 hour(s) ago
Aurobindo Pharma gets nod to raise $350 million via QIP - 6 day(s) ago
Japanese Co Drags APL to US Court - 2 day(s) ago
Opposition parties extend support to Aurobindo Pharma employees - 4 day(s) ago

BSE Announcements from Aurobindo Pharma Ltd. (See all)

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 19 Jan 2015
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 19 Jan 2015

Company details for Aurobindo Pharma Ltd.

Report Card

PE Ratios
29.31
EPS (Rs.)
40.21
Sales (Rs. Cr)
2,007.70
Face Value (Rs.)
1
Net Profit
Margin (%)
 
16.31
Last Bonus
1:1
Last Dividend(%)
150
Return on
Average Equity
 
29.21

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Aurobindo Pharma Ltd. performance snapshot

If you had invested Rs.  in Aurobindo Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Aurobindo Pharma Ltd. with other stocks

Cadila Healthcare Ltd.
1,659.70
Piramal Enterprises Ltd.
844.05
Show more companies
Cadila Healthcare Ltd.
1,659.70
Piramal Enterprises Ltd.
844.05
Dr. Reddy's Laboratories Ltd.
3,238.10
Fortis Healthcare Ltd.
113.00
Lupin Ltd.
1,513.35
Ranbaxy Laboratories Ltd.
699.75
Torrent Pharmaceuticals Ltd.
1,209.10
Alembic Pharmaceuticals Ltd.
487.15
GlaxoSmithKline Pharmaceuticals Ltd.
3,384.30
Apollo Hospitals Enterprise Ltd.
1,415.50
Show less companies
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close